CVE-2023-51698

Mate-desktop Atril command injection

9.6 CRITICALEPSS 2.36%

Published12 Jan 2024

Description

Atril is a simple multi-page document viewer. Atril is vulnerable to a critical Command Injection Vulnerability. This vulnerability gives the attacker immediate access to the target system when the target user opens a crafted document or clicks on a crafted link/URL using a maliciously crafted CBT document which is a TAR archive. A patch is available at commit ce41df6.

CVSS 3.1 breakdown

Attack vectorNetwork

Attack complexityLow

Privileges requiredNone

User interactionRequired

ScopeChanged

ConfidentialityHigh

IntegrityHigh

AvailabilityLow

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:L

Affected products

Mate-desktop Atril≤ 1.26.3

Remediation

No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.

Frequently asked

Is CVE-2023-51698 being actively exploited?

CVE-2023-51698 is not in the CISA KEV catalog. Its EPSS exploit probability is 2.36%.

How severe is CVE-2023-51698?

CVE-2023-51698 has a CVSS 3.1 base score of 9.6, rated critical. EPSS estimates a 2.36% probability of exploitation.

Which products are affected by CVE-2023-51698?

Affected products include Mate-desktop Atril.

How do I fix CVE-2023-51698?

Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.

How Secuno handles this

Secuno correlates vulnerabilities like CVE-2023-51698 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.

See how prioritisation works Book a demo

Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.